newsfilter
← Latest News
Business Wire·

Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results

– Fourth Quarter 2022 Total Revenue of $36.3 Million and Full Year 2022 Revenue of $134.0 Million; QINLOCK® Net Product Revenue Increased 44% to $125.5 Million in 2022 Compared to 2021 – – Expects to Complete